{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:01:58Z","timestamp":1747206118505,"version":"3.40.5"},"reference-count":16,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DHPS"],"DOI":"10.2147\/dhps.s254723","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T20:28:12Z","timestamp":1597955292000},"page":"145-149","source":"Crossref","is-referenced-by-count":1,"title":["<p>Amoxicillin and Risk of Hearing Loss: Analysis of Reported Cases Submitted to the WHO Global Database<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1939-5842","authenticated-orcid":true,"given":"Mulugeta","family":"Russom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-9858","authenticated-orcid":true,"given":"Aziza","family":"Afendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-6285","authenticated-orcid":true,"given":"Amon Solomon","family":"Ghebrenegus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,8]]},"reference":[{"volume-title":"Handbook of Sensory Physiology","year":"1976","key":"ref1"},{"key":"ref2","unstructured":"America Society of Health-System Pharmacists. American hospital formulary services drug information. 1984."},{"key":"ref3","unstructured":"European Medicines Agency. Summary of characteristics of Amoxicillin 500mg\/25mg capsules and 125\/5ml\/250mg\/5ml powder for suspension. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/amoxil-article-30-referral-annex-iii_en.pdf. Accessed September 18, 2019."},{"key":"ref4","unstructured":"European Medicines Agency. Summary of characteristics of Amoxicillin 500 mg capsule."},{"key":"ref5","unstructured":"Medicines and Healthcare Products Regulatory Agency. Summary of characteristics of Amoxicillin 500 mg capsule. Aurobindo Pharma - Milpharm Ltd; Available from: https:\/\/www.medicines.org.uk\/emc\/product\/526\/smpc. Accessed September 18, 2019."},{"key":"ref6","unstructured":"Medicines and Healthcare Products Regulatory Agency. Summary of characteristics of Amoxicillin 250mg\/500mg\/1gm capsule. Wockhardt UK Ltd; Available from: https:\/\/www.medicines.org.uk\/emc\/product\/526\/smpc. Accessed September 18, 2019"},{"key":"ref7","unstructured":"United States Food and Drug Administration. Prescribing information of Amoxicillin 250\/500 mg capsules and 125mg\/5ml, 200mg\/5ml, 250mg\/5ml, 400mg\/5ml powder for suspension. Available from: https:\/\/www.drugs.com\/ppa\/amoxicillin.html. Accessed September 18, 2019."},{"key":"ref8","unstructured":"United States Food and Drug Administration. Prescribing information of Amoxicillin 250\/500 mg capsules and 125\/250mg\/5ml powder for suspension. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050760s11,050761s11,050754s12,050542s25lbl.pdf. Accessed September 18, 2019."},{"key":"ref9","unstructured":"Eritrea Medicines and Food Administration. Summary of characteristics of Amoxicillin 500\/250 mg capsule, Azel Pharma."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12070-011-0151-8","volume":"63","author":"Bisht","year":"2011","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref11","unstructured":"Uppsala Monitoring Center. WHO global individual case safety reports database. Available from: https:\/\/www.who-umc.org\/vigibase\/vigibase\/. Accessed March 17, 2019."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40264-013-0095-x","volume":"36","author":"Nor\u00e9n","year":"2013","journal-title":"Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/003591576505800503","volume":"58","author":"Hill","year":"1965","journal-title":"Proc Royal Soc Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archotol.1989.01860320050017","volume":"115","author":"Brown","year":"1989","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"Knight","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Drug, Healthcare and Patient Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=60836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=60836","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T20:28:21Z","timestamp":1597955301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/amoxicillin-and-risk-of-hearing-loss-analysis-of-reported-cases-submit-peer-reviewed-article-DHPS"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":16,"URL":"https:\/\/doi.org\/10.2147\/dhps.s254723","relation":{},"ISSN":["1179-1365"],"issn-type":[{"type":"electronic","value":"1179-1365"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}